Cardiac Imaging

March 25,  2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets cardiac MRI scans with performance approaching expert clinicians.

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the latest computer-assisted detection (CADe) radiography solution from Qure.ai.

Jan. 7, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has partnered with Jefferson Health, one of the largest academic health systems in the United States, in a clinical study to advance rapid incorporation of diagnostic-quality FoCUS echocardiogram workflows.

Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis, has introduced its PlaqueIQ image analysis software for the quantification and classification of plaque…

Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for electrophysiology (EP) and interventional cardiology (IC) procedures, recently announced that the U.S.